Abstract
Clinical studies show an association between inflammation and arterial stiffness. We and others have shown that T cells are involved in hypertension; however their role in aortic stiffening is unknown. We hypothesized that T cells mediate angiotensin II-induced aortic stiffening. Using a pressurized myograph system, we determined aortic stiffness and quantified this using a distensibility index (DI), defined as the percent change in aortic outer diameter from 75 mmHg to 125 mmHg. Angiotensin II (490ng/kg/min for 14 days) markedly decreased the distensibility index in C57Bl/6 mice (23.8±5.5 v.s. 8.9±4.1, p<0.01, n=8), and this was almost completely prevented in RAG-1 -/- mice (18.3±4.0, p<0.01 compared with C57Bl/6, n=8). Adoptive transfer of pan T cells into RAG-1 -/- mice restored aortic stiffness in RAG-1 -/- (11.9±2.6, p<0.05, n=5). The effect of T cell-derived pro-inflammatory cytokines on aortic stiffening was examined using interferon-γ (IFN-γ -/- ) and IL-6 -/- mice. Deficiency of INF-γ partially restored aortic distensibility (17.0±3.5 v.s. 8.9±4.1, p<0.01, n=8) compared C57Bl/6 mice treated with angiotensin II. Aortic distensibility was also preserved in IL-6 -/- mice (19.9±5.9 v.s. 8.9±4.1, p<0.01, n=8) treated with angiotensin II. In contrast to these functional alterations, the increase in collagen caused by angiotensin II was similar between wild-type and RAG-1 -/- mice. There was no change in elastin abundance with angiotensin II treatment or in different mouse strains. In conclusion, T cells are essential for angiotensin II-induced collagen deposition, vascular hypertrophy and aortic stiffening. Part of these effects could be mediated by pro-inflammatory cytokines such as INF-γ and IL-6. These likely mediate aortic stiffening by altering properties of elastin and collagen such as crosslinking, rather than alter total abundance of these proteins.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have